financetom
Business
financetom
/
Business
/
Marsh McLennan beats profit estimates on risk and insurance business strength
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marsh McLennan beats profit estimates on risk and insurance business strength
Jan 30, 2025 5:25 AM

Jan 30 (Reuters) - Insurance brokerage and consulting

company Marsh McLennan's ( MMC ) fourth-quarter profit beat Wall

Street estimates on Thursday, as its risk and insurance business

recorded strong growth.

WHY IT'S IMPORTANT

Insurers have consistently raised policy prices in recent

years in response to losses from wars and natural catastrophes,

along with inflationary pressures.

The sector usually sees steady or even heightened demand

during economic uncertainty. Strong demand trends in the broader

industry have also boosted income for brokerages like Marsh &

McLennan ( MMC ), which earn commissions based on insurance premiums.

BY THE NUMBERS

On an adjusted basis, the New York-based firm earned $927

million for the quarter ended Dec. 31, or $1.87 per share.

Analysts on average were expecting $1.76 per share,

according to data compiled by LSEG.

It reported a total revenue of $6.07 billion in the quarter,

up 9.2% from last year.

Marsh McLennan's ( MMC ) risk and insurance services business posted

revenue growth of 11.5%, while its consulting arm's revenue

climbed 6.1%.

Its fiduciary interest income - earnings on funds held on

behalf of clients - fell 9% to $112 million.

CONTEXT

Marsh McLennan ( MMC ), through its four subsidiaries - Marsh,

Mercer, Oliver Wyman, and Guy Carpenter - provides risk,

insurance, and consulting services in over 130 countries.

The company went on a $10 billion acquisition spree in 2024,

including the $7.75 billion purchase of McGriff, completed in

November.

Earlier this week, insurance brokerage Brown & Brown ( BRO )

also beat fourth-quarter profit estimates, driven by robust

growth in investment returns and increased commissions and fees.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Calliditas Therapeutics' Partner Launches Japanese Trial for IgA Nephropathy Treatment
Calliditas Therapeutics' Partner Launches Japanese Trial for IgA Nephropathy Treatment
Jul 5, 2024
03:56 AM EDT, 07/05/2024 (MT Newswires) -- Calliditas Therapeutics ( CALT ) said Thursday its partner Viatris Pharmaceutical Japan has launched a phase 3 clinical trial in Japan of Nefecon as a potential treatment for Japanese patients with IgA nephropathy, a disease of the kidney and the immune system. Calliditas licenses Nefecon, which is called VR-205 in Japan, to Viatris...
Grupo Aeroportuario del Pacifico Says 2 Jamaica Airports Suffered No Major Hurricane Damage
Grupo Aeroportuario del Pacifico Says 2 Jamaica Airports Suffered No Major Hurricane Damage
Jul 5, 2024
04:12 AM EDT, 07/05/2024 (MT Newswires) -- Grupo Aeroportuario del Pacifico (PAC) said Thursday that two Jamaican airports in which it holds financial interests or operates did not suffer any major damage as a result of Hurricane Beryl, though both airports closed July 2 to July 3 as a preventative measure. Montego Bay's Sangster International Airport, which holds a majority...
AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook
AbbVie Flags Hit to Q2 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook
Jul 5, 2024
03:57 AM EDT, 07/05/2024 (MT Newswires) -- AbbVie ( ABBV ) expects its Q2 adjusted earnings to take a $0.52 per-share hit from acquired in-process research and development and milestones expense of $937 million on a pre-tax basis, according to a Wednesday regulatory filing. The company expects Q2 adjusted EPS of $2.53 to $2.57, including the impact, the filing showed....
US judge partially blocks FTC ban on worker noncompete agreements
US judge partially blocks FTC ban on worker noncompete agreements
Jul 5, 2024
(Reuters) -A federal judge in Texas on Wednesday partially blocked a U.S. Federal Trade Commission rule from taking effect that would ban agreements commonly signed by workers not to join their employers' rivals or launch competing businesses. U.S. District Judge Ada Brown in Dallas said in a written decision the FTC, which enforces federal antitrust laws, lacked the power to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved